Chiara Broglia

1.5k total citations
20 papers, 662 citations indexed

About

Chiara Broglia is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chiara Broglia has authored 20 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Chiara Broglia's work include Lymphoma Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Chiara Broglia is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Lung Cancer Treatments and Mutations (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Chiara Broglia collaborates with scholars based in Italy, United Kingdom and France. Chiara Broglia's co-authors include Paolo G. Gobbi, Luca Baldini, Giampaolo Merlini, Francesco Merli, Mario Comelli, Maria Goldaniga, Giorgio La Nasa, Edoardo Ascari, Emilio Iannitto and Caterina Stelitano and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Chiara Broglia

20 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chiara Broglia Italy 13 396 248 184 166 147 20 662
Alessia Bari Italy 19 550 1.4× 449 1.8× 179 1.0× 179 1.1× 119 0.8× 53 911
Judith Huerta‐Guzmán Mexico 17 400 1.0× 400 1.6× 97 0.5× 133 0.8× 96 0.7× 42 666
Raffaella Marcheselli Italy 13 304 0.8× 323 1.3× 108 0.6× 160 1.0× 70 0.5× 30 594
Delia Rota Scalabrini Italy 11 447 1.1× 290 1.2× 97 0.5× 84 0.5× 134 0.9× 25 600
Chiara Bottelli Italy 11 410 1.0× 307 1.2× 182 1.0× 154 0.9× 53 0.4× 24 685
Bruno Anglaret France 13 241 0.6× 394 1.6× 150 0.8× 302 1.8× 78 0.5× 31 762
Lorella Orsucci Italy 15 713 1.8× 356 1.4× 441 2.4× 132 0.8× 82 0.6× 45 892
David Topolsky United States 15 141 0.4× 348 1.4× 93 0.5× 337 2.0× 123 0.8× 39 884
J O Armitage United States 7 493 1.2× 298 1.2× 214 1.2× 43 0.3× 103 0.7× 9 609
Marcel Hayat France 12 264 0.7× 160 0.6× 97 0.5× 168 1.0× 135 0.9× 20 579

Countries citing papers authored by Chiara Broglia

Since Specialization
Citations

This map shows the geographic impact of Chiara Broglia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiara Broglia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiara Broglia more than expected).

Fields of papers citing papers by Chiara Broglia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiara Broglia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiara Broglia. The network helps show where Chiara Broglia may publish in the future.

Co-authorship network of co-authors of Chiara Broglia

This figure shows the co-authorship network connecting the top 25 collaborators of Chiara Broglia. A scholar is included among the top collaborators of Chiara Broglia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiara Broglia. Chiara Broglia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ciani, Oriana, Maria Cucciniello, Francesco Petracca, et al.. (2019). Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer. BMJ Open. 9(2). e025483–e025483. 30 indexed citations
2.
Miccinesi, Guido, Augusto Caraceni, Ferdinando Garetto, et al.. (2019). The Path of Cicely Saunders: The “Peculiar Beauty” of Palliative Care. Journal of Palliative Care. 35(1). 3–7. 15 indexed citations
3.
D’Arena, Giovanni, Paolo G. Gobbi, Chiara Broglia, et al.. (2011). Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study. Leukemia & lymphoma. 52(5). 771–775. 74 indexed citations
4.
Gobbi, P., Chiara Broglia, Francesco Valentino, et al.. (2006). The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL). Annals of Oncology. 17(4). 676–682. 3 indexed citations
5.
Gobbi, Paolo G., Chiara Broglia, Alessandro Levis, et al.. (2006). MOPPEBVCAD Chemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin's Lymphoma: 10-Year Results, Late Toxicity, and Second Tumors. Clinical Cancer Research. 12(2). 529–535. 11 indexed citations
6.
Broglia, Chiara, et al.. (2006). [Avascular jaw osteonecrosis associated with bisphophonate therapy].. PubMed. 97(3). 140–4. 3 indexed citations
7.
9.
Pozzi, Samantha, Raffaella Marcheselli, Stefano Sacchi, et al.. (2005). Analysis of Frequency and Risk Factors for Developing Bisphosphonate Associated Osteonecrosis of the Jaw.. Blood. 106(11). 5057–5057. 24 indexed citations
11.
Gobbi, Paolo G., Chiara Broglia, Giuseppe Di Giulio, et al.. (2004). The clinical value of tumor burden at diagnosis in Hodgkin lymphoma. Cancer. 101(8). 1824–1834. 36 indexed citations
12.
Gobbi, Paolo G., Chiara Broglia, Francesco Merli, et al.. (2003). Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early‐stage, favorable Hodgkin lymphoma. Cancer. 98(11). 2393–2401. 20 indexed citations
13.
Merlini, Giampaolo, Luca Baldini, Chiara Broglia, et al.. (2003). Prognostic factors in symptomatic Waldenstrom's macroglobulinemia. Seminars in Oncology. 30(2). 211–215. 66 indexed citations
15.
Gobbi, Paolo G., et al.. (2002). Lymphomatous superficial lymph nodes: limitations of physical examination for accurate staging and response assessment.. PubMed. 87(11). 1151–6. 11 indexed citations
16.
Gobbi, Paolo G., Pier Luigi Zinzani, Chiara Broglia, et al.. (2001). Comparison of prognostic models in patients with advanced Hodgkin disease. Cancer. 91(8). 1467–1478. 33 indexed citations
17.
Gobbi, Paolo G., Marco Solcia, Giuseppe Di Giulio, et al.. (2001). Image-Aided Estimate of Tumor Burden in Hodgkin’s Disease: Evidence of Its Primary Prognostic Importance. Journal of Clinical Oncology. 19(5). 1388–1394. 50 indexed citations
18.
Broglia, Chiara, Raffaella Bertè, S. Molica, et al.. (2000). Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.. PubMed. 85(7). 722–8. 3 indexed citations
19.
Gobbi, Paolo G., Paolo Avanzini, Luca Baldini, et al.. (2000). A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).. PubMed. 85(3). 263–8. 5 indexed citations
20.
Gobbi, Paolo G., Luca Baldini, Chiara Broglia, et al.. (2000). The role of surgery in the treatment of gastrointestinal lymphomas other than low-grade MALT lymphomas.. PubMed. 85(4). 372–80. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026